Albert Bakker

1.4k total citations
28 papers, 1.1k citations indexed

About

Albert Bakker is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Family Practice. According to data from OpenAlex, Albert Bakker has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 11 papers in Geriatrics and Gerontology and 6 papers in Family Practice. Recurrent topics in Albert Bakker's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Blood Pressure and Hypertension Studies (10 papers) and Sleep and related disorders (6 papers). Albert Bakker is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Blood Pressure and Hypertension Studies (10 papers) and Sleep and related disorders (6 papers). Albert Bakker collaborates with scholars based in Netherlands, United States and Sweden. Albert Bakker's co-authors include Arsenio H.P. Paes, Olaf H. Klungel, Anthonius de Boer, Jacob C. Seidell, Hubert G. M. Leufkens, Rolf van Hulten, Ron M. C. Herings, Bruno H. Stricker, Ruud Jonkers and Lyda Blom and has published in prestigious journals such as Diabetes Care, Stroke and Social Science & Medicine.

In The Last Decade

Albert Bakker

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Bakker Netherlands 17 290 255 235 234 149 28 1.1k
María Christou Greece 14 156 0.5× 240 0.9× 165 0.7× 87 0.4× 117 0.8× 37 1.4k
Pamela C. Heaton United States 23 286 1.0× 301 1.2× 98 0.4× 151 0.6× 137 0.9× 83 1.4k
Emiliano Sessa Italy 14 492 1.7× 172 0.7× 73 0.3× 293 1.3× 163 1.1× 33 1.1k
Emmae Ramsay Australia 24 285 1.0× 529 2.1× 203 0.9× 140 0.6× 183 1.2× 55 1.6k
Ovidio Brignoli Italy 18 647 2.2× 199 0.8× 127 0.5× 354 1.5× 305 2.0× 52 1.4k
Ida Fortino Italy 24 450 1.6× 337 1.3× 275 1.2× 118 0.5× 312 2.1× 108 1.9k
Line Guénette Canada 17 111 0.4× 312 1.2× 232 1.0× 327 1.4× 123 0.8× 96 1.1k
Marianna Alacqua Italy 13 423 1.5× 176 0.7× 70 0.3× 288 1.2× 142 1.0× 22 1.1k
Abel Thijs Netherlands 26 164 0.6× 379 1.5× 129 0.5× 131 0.6× 169 1.1× 77 1.9k
Susan Ogle Australia 15 206 0.7× 305 1.2× 121 0.5× 91 0.4× 131 0.9× 27 1.0k

Countries citing papers authored by Albert Bakker

Since Specialization
Citations

This map shows the geographic impact of Albert Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Bakker more than expected).

Fields of papers citing papers by Albert Bakker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Bakker. The network helps show where Albert Bakker may publish in the future.

Co-authorship network of co-authors of Albert Bakker

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Bakker. A scholar is included among the top collaborators of Albert Bakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Bakker. Albert Bakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hulten, Rolf van, et al.. (2005). Initial benzodiazepine use and improved health-related quality of life. Pharmacy World & Science. 27(1). 41–46. 4 indexed citations
2.
Blom, Lyda, et al.. (2004). Effects of a management technician on structured working in Dutch community pharmacies. Pharmacy World & Science. 26(4). 221–226. 4 indexed citations
3.
Hulten, Rolf van, et al.. (2003). The impact of attitudes and beliefs on length of benzodiazepine use: a study among inexperienced and experienced benzodiazepine users. Social Science & Medicine. 56(6). 1345–1354. 24 indexed citations
4.
Hulten, Rolf van, et al.. (2003). Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up. European Journal of Clinical Pharmacology. 58(10). 689–694. 25 indexed citations
5.
Blom, Lyda, et al.. (2002). Patient oriented activities in Dutch community pharmacy: diffusion of innovations.. Pharmacy World & Science. 24(4). 154–161. 21 indexed citations
6.
Blom, Lyda, et al.. (2002). Community pharmacy and patient-oriented activities: the Dutch case. Patient Education and Counseling. 46(1). 39–45. 25 indexed citations
7.
Hulten, Rolf van, et al.. (2001). Determinants of change in the intention to use benzodiazepines.. Pharmacy World & Science. 23(2). 70–75. 5 indexed citations
8.
Klungel, Olaf H., Arsenio H.P. Paes, Anthonius de Boer, et al.. (2000). Sex differences in the medication choice for hypertension in general practice. A study with written case simulations.. Pharmacy World & Science. 22(4). 140–146. 7 indexed citations
9.
Klungel, Olaf H., Anthonius de Boer, Arsenio H.P. Paes, et al.. (2000). Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure. Journal of Clinical Epidemiology. 53(11). 1158–1163. 34 indexed citations
10.
Klungel, Olaf H., Anthonius de Boer, Arsenio H.P. Paes, et al.. (2000). Influence of question structure on the recall of self-reported drug use. Journal of Clinical Epidemiology. 53(3). 273–277. 91 indexed citations
11.
Hulten, Rolf van, Eibert R. Heerdink, Albert Bakker, & Hubert G. M. Leufkens. (1999). Benzodiazepine pathways in the chronically ill. Pharmacoepidemiology and Drug Safety. 8(5). 325–330. 8 indexed citations
12.
Klungel, Olaf H., et al.. (1999). Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands.. Pharmacy World & Science. 21(5). 217–220. 56 indexed citations
13.
Klungel, Olaf H., Anthonius de Boer, Arsenio H.P. Paes, Jacob C. Seidell, & Albert Bakker. (1998). Sex differences in antihypertensive drug use. Journal of Hypertension. 16(10). 1545–1553. 49 indexed citations
14.
Hulten, Rolf van, Hubert G. M. Leufkens, & Albert Bakker. (1998). Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up.. Pharmacy World & Science. 20(2). 78–82. 40 indexed citations
15.
Klungel, Olaf H., Anthonius de Boer, Arsenio H.P. Paes, et al.. (1998). Undertreatment of hypertension in a population-based study in The Netherlands. Journal of Hypertension. 16(9). 1371–1378. 37 indexed citations
16.
Blom, Lyda, Ruud Jonkers, Gerjo Kok, & Albert Bakker. (1998). Patient Education in 20 Dutch Community Pharmacies: Analysis of Audiotaped Patient Contacts. International Journal of Pharmacy Practice. 6(2). 72–76. 14 indexed citations
17.
Egberts, Toine C. G., Ronald H.B. Meyboom, Fred H.P. De Koning, Albert Bakker, & Hubert G. M. Leufkens. (1997). Non‐puerperal lactation associated with antidepressant drug use. British Journal of Clinical Pharmacology. 44(3). 277–281. 52 indexed citations
18.
Klungel, Olaf H., Anthonius de Boer, Arsenio H.P. Paes, Jacob C. Seidell, & Albert Bakker. (1997). Sex differences in the pharmacological treatment of hypertension. Journal of Hypertension. 15(6). 591–600. 48 indexed citations
19.
Herings, Ron M. C., Bruno H. Stricker, Anthonius de Boer, et al.. (1996). Current use of thiazide diuretics and prevention of femur fractures. Journal of Clinical Epidemiology. 49(1). 115–119. 58 indexed citations
20.
Herings, Ron M. C., Bruno H. Stricker, Hubert G. M. Leufkens, et al.. (1993). Public health problems and the rapid estimation of the size of the population at risk. Pharmacy World & Science. 15(5). 212–218. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Christou Breakdown of academic impact, for papers by Pamela C. Heaton Breakdown of academic impact, for papers by Emiliano Sessa Breakdown of academic impact, for papers by Emmae Ramsay Breakdown of academic impact, for papers by Ovidio Brignoli Breakdown of academic impact, for papers by Ida Fortino Breakdown of academic impact, for papers by Line Guénette Breakdown of academic impact, for papers by Marianna Alacqua Breakdown of academic impact, for papers by Abel Thijs Breakdown of academic impact, for papers by Susan Ogle
Rankless by CCL
2026